Related Experiment Video
Updated: May 27, 2026

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
The effect of motion correction on pharmacokinetic parameter estimation in dynamic-contrast-enhanced MRI
A Melbourne1, J Hipwell, M Modat
1Centre for Medical Image Computing, University College London, Gower Street, London WC1E 6BT, UK. a.melbourne@cs.ucl.ac.uk
Abstract:
A dynamic-contrast-enhanced magnetic resonance imaging (DCE-MRI) dataset consists of many imaging frames, often acquired both before and after contrast injection. Due to the length of time spent acquiring images, patient motion is likely and image re-alignment or registration is required before further analysis such as pharmacokinetic model fitting. Non-rigid image registration procedures may be used to correct motion artefacts; however, a careful choice of registration strategy is required to reduce misregistration artefacts associated with enhancing features. This work investigates the effect of registration on the results of model-fitting algorithms for 52 DCE-MR mammography cases for 14 patients. Results are divided into two sections: a comparison of registration strategies in which a DCE-MRI-specific algorithm is preferred in 50% of cases, followed by an investigation of parameter changes with known applied deformations, inspecting the effect of magnitude and timing of motion artefacts. Increased motion magnitude correlates with increased model-fit residual and is seen to have a strong influence on the visibility of strongly enhancing features. Motion artefacts in images close to the contrast agent arrival have a disproportionate effect on discrepancies in parameter estimation. The choice of algorithm, magnitude of motion and timing of the motion are each shown to influence estimated pharmacokinetic parameters even when motion magnitude is small.
Insights
Patient motion in dynamic-contrast-enhanced MRI (DCE-MRI) can affect pharmacokinetic analysis. This study shows that registration strategy, motion magnitude, and timing significantly influence DCE-MRI model-fitting results.
Area of Science:
- Medical Imaging
- Radiology
- Biophysics
Background:
- Dynamic-contrast-enhanced MRI (DCE-MRI) requires image registration to correct for patient motion before pharmacokinetic analysis.
- Non-rigid registration is used, but careful strategy selection is needed to avoid misregistration artifacts, especially with enhancing features.
Purpose of the Study:
- To investigate the impact of different image registration strategies on pharmacokinetic model-fitting results in DCE-MR mammography.
- To analyze the influence of motion magnitude and timing on parameter estimation.
Main Methods:
- Evaluated 52 DCE-MR mammography cases from 14 patients.
- Compared various registration strategies, including a DCE-MRI-specific algorithm.
- Assessed parameter changes under controlled deformations to study motion effects.
Main Results:
- A DCE-MRI-specific registration algorithm was preferred in 50% of cases.
- Increased motion magnitude correlated with higher model-fit residuals and affected enhancing features.
- Motion occurring near contrast arrival had a disproportionate impact on parameter discrepancies.
Conclusions:
- Registration algorithm choice, motion magnitude, and timing critically influence DCE-MRI pharmacokinetic parameter estimation.
- Even small motion magnitudes can significantly alter results, underscoring the need for optimized registration techniques.
Related Concept Videos
Pharmacodynamic Models: Linear Concentration–Effect Model
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

